Literature DB >> 10189269

Influence of pH, temperature and buffers on cefepime degradation kinetics and stability predictions in aqueous solutions.

J O Fubara1, R E Notari.   

Abstract

First-order rate constants (k) were determined for cefepime degradation at 45, 55, 65, and 75 degrees C, pH 0.5 to 8.6, using an HPLC assay. Each pH-rate profile exhibited an inflection between pH 1 and 2. The pH-rate expression was k(pH) = kH1 f1(aH+) + kH2 f2(aH+) + ks + kOH(aOH-), where kH1 and kH2 are the catalytic constants (M(-1) h(-1)) for hydrogen ion activity (aH+), kOH is the catalytic constant for hydroxyl ion activity (aOH-), and ks is the first-order rate constant (h(-1)) for spontaneous degradation. The protonated (f1) and unprotonated (f2) fractions were calculated from the dissociation constant, Ka = (8.32x10(-6))e(5295)/RT where T was absolute temperature (T). Accelerated loss due to formate, acetate, phosphate, and borate buffer catalysis was quantitatively described with the catalytic constant, kGA (M(-1) h(-1)) for the acidic component, [GA], and kGB (M(-1) h(-1) for the basic component, [GB], of each buffer. The temperature dependency for each rate constant was defined with experimentally determined values for A and E and the Arrhenius expression, kT = Ae-E/RT, where kT represented kH1, kH2 , kS, kOH, kGA, or kGB. Degradation rate constants were calculated for all experimental pH, temperature, and buffer conditions by combining the contributions from pH and buffer effects to yield, k = k(pH) + kGA[GA] + kGB[GB]. The calculated k values had <10% error for 103 of the 106 experimentally determined values. Maximum stability was observed in the pH-independent region, 4 to 6. Degradation rate constants were predicted and experimentally verified for cefepime solutions stored at 30 degrees C, pH 4.6 and 5.6. These solutions maintained 90% of their initial concentration (T90) for approximately 2 days.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10189269     DOI: 10.1021/js980170y

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  Pitfalls in cefepime titration from human plasma: plasma- and temperature-related drug degradation in vitro.

Authors:  Denis Bugnon; Eric Giannoni; Paul Majcherczyk; Michel P Glauser; Philippe Moreillon
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

2.  Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units).

Authors:  Eric Viaene; Hugues Chanteux; Hélène Servais; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

3.  Stability and antibacterial activity of cefepime during continuous infusion.

Authors:  Pål F Sprauten; Paul M Beringer; Stan G Louie; Timothy W Synold; Mark A Gill
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

4.  Study on degradation kinetics of epalrestat in aqueous solutions and characterization of its major degradation products under stress degradation conditions by UHPLC-PDA-MS/MS.

Authors:  Hong Sun; Suyan Liu; Xun Gao; Zhili Xiong; Zhonggui He; Longshan Zhao
Journal:  J Pharm Anal       Date:  2018-08-15

5.  Stability and Compatibility Aspects of Drugs: The Case of Selected Cephalosporins.

Authors:  Szymon Tomczak; Aleksandra Gostyńska; Malwina Nadolna; Karolina Reisner; Marta Orlando; Anna Jelińska; Maciej Stawny
Journal:  Antibiotics (Basel)       Date:  2021-05-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.